Drugs Flashcards

1
Q

Metformin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

A. Biguanides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alogliptin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

B. DPP-4 Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sitagliptin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

B. DPP-4 Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dulaglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

C. GLP-1 Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Liraglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

C. GLP-1 Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Semaglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

C. GLP-1 Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dapagliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

E. SGLT-2 Inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Empagliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

E. SGLT-2 Inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glipizide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

F. Sufonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pioglitazone
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

A

G. TZD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which of the following are agents that enhance insulin secretion?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

F. Sulfonylurea
G. Meglitinides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glyburide, Glipizide, and Glimepiride are examples of what medication group?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

F. Sulfonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nateglinide and Repaglinide are examples of what medication group?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

G. Meglitinides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Agents that enhance _____ secretion include sulfonylureas with (short/prolonged) duration of action vs meglitinides with a (short/prolonged) duration of action.

A

Agents that enhance insulin secretion include sulfonylureas with prolonged duration of action vs meglitinides with a short duration of action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Agents that enhance the incretin effect
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

B. DPP-4 Inhibitors
C. GLP-1 Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Exenatide, Liraglutide, Lixenatide, Dulaglutide, and Semaglutide are examples of which group
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

C. GLP-1 Agonist

17
Q

Saxagliptin, Sitagliptin, Linagliptin and Alogliptin are examples of which class
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

B. DPP-4 Inhibitors

18
Q

Which are agents that reduce glucose absorption or increase glucose excretion
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

E. SGLT-2 Inhibitor

19
Q

Canagliflozin, Empagliflozin, Dapagliflozin, and Ertugliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

E. SGLT-2 Inhibitor

20
Q

Agents that reduce insulin resistance/lipotoxicity
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

A. Biguanides
H. TZD

21
Q

Metformin is an example of which drug group
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

A. Biguanides

22
Q

Pioglitazone and Rosiglitazone are examples of what class
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

A

H. TZD

23
Q

Humulin-R U500 has which maximum dose delivery
A. 60 units
B. 80 units
C. 160 units
D. 300 units

A

D. 300 units

24
Q

Degludec U200 (Tresiba) has which maximum dose delivery
A. 60 units
B. 80 units
C. 160 units
D. 300 units

A

C. 160 units

25
Q

Degludec U300 (Toujeo) has which maximum dose delivery
A. 60 units
B. 80 units
C. 160 units
D. 300 units

A

B. 80 units

26
Q

Degludec U 300 (Toujeo Max) has which maximum dose delivery
A. 60 units
B. 80 units
C. 160 units
D. 300 units

A

C. 160 units

27
Q

Lispro U200 (Humalog Kwikpen) has which maximum dose delivery
A. 60 units
B. 80 units
C. 160 units
D. 300 units

A

A. 60 units

28
Q

Humulin-R U500 come in which unit increment
A. 1
B. 2
C. 3
D. 4
E. 5

A

E. 5

29
Q

Degludec U200 (Tresiba) come in which unit increment
A. 1
B. 2
C. 3
D. 4
E. 5

A

B. 2

30
Q

Glargine U300 (Toujeo) come in which unit increment
A. 1
B. 2
C. 3
D. 4
E. 5

A

A. 1

31
Q

Glargine U 300 (Toujeo Max) come in which unit increment
A. 1
B. 2
C. 3
D. 4
E. 5

A

B. 2

32
Q
A